Ehrlichial invasin for immunization, diagnosis, and cell delivery
Disclosed are vaccines containing one or more immunogenic polypeptides derived from an EtpE protein from an Ehrlichia sp. or nucleic acid encoding these polypeptides. Also disclosed is a method for vaccinating a subject against Ehrlichia sp. that involves administering to the subject a composition comprising any of the disclosed vaccines. Also disclosed is a method for diagnosing and/or monitoring the treatment of Ehrlichiosis in a subject that comprising assaying a biological sample (e.g., blood, serum, or plasma sample) from the subject for the presence of an antibody that specifically binds an EtpE polypeptide. Also disclosed are methods for delivering a therapeutic or diagnostic agent to a cell in a subject that involves conjugating the agent, or a delivery vehicle comprising the agent, to polypeptide containing the C-terminal domain of an EtpE protein.
1. A method of treating a subject with Ehrlichiosis, the method comprising: diagnosing Ehrlichiosis in the subject, wherein said diagnosing comprises assaying a biological sample from the subject for the presence of an antibody that specifically binds a polypeptide comprising SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, or a conservative variant thereof having at least 70% identity to SEQ ID NO:7, SEQ ID NO:8, or SEQ ID NO:9, wherein the presence of the antibody is an indication that the subject has been infected with an Ehrlichia sp., and treating the subject diagnosed with Ehrlichiosis accordingly.
2. The method of claim 1 , wherein the presence of the antibody is an indication that the subject has been infected with an Ehrlichia sp. selected from the group consisting of Ehrlichia chaffeensis, Ehrlichia canis , and Ehrlichia ruminantium.
3. The method of claim 1 , comprising treating the subject with an effective amount and duration of doxycycline.
4. The method of claim 1 , wherein the biological sample is a blood, serum, or plasma sample.